These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 8449607)
1. Inhibition by dehydroepiandrosterone of butylated hydroxyanisole (BHA) promotion of rat-bladder carcinogenesis and enhancement of BHA-induced forestomach hyperplasia. Shibata MA; Shirai T; Asakawa E; Hirose M; Fukushima S Int J Cancer; 1993 Mar; 53(5):819-23. PubMed ID: 8449607 [TBL] [Abstract][Full Text] [Related]
2. Chemoprevention by indomethacin of tumor promotion in a rat urinary bladder carcinogenesis model. Shibata MA; Hasegawa R; Shirai T; Takesada Y; Fukushima S Int J Cancer; 1993 Dec; 55(6):1011-7. PubMed ID: 8253519 [TBL] [Abstract][Full Text] [Related]
3. Modifying effects of simultaneous treatment with butylated hydroxyanisole (BHA) on rat tumor induction by 3,2'-dimethyl-4-aminobiphenyl, 2,2'-dihydroxy-di-n-propylnitrosamine and N-methylnitrosourea. Ito N; Hirose M; Shibata M; Tanaka H; Shirai T Carcinogenesis; 1989 Dec; 10(12):2255-9. PubMed ID: 2591015 [TBL] [Abstract][Full Text] [Related]
4. Promoting activities of butylated hydroxyanisole, butylated hydroxytoluene and sodium L-ascorbate on forestomach and urinary bladder carcinogenesis initiated with methylnitrosourea in F344 male rats. Imaida K; Fukushima S; Shirai T; Masui T; Ogiso T; Ito N Gan; 1984 Sep; 75(9):769-75. PubMed ID: 6500233 [TBL] [Abstract][Full Text] [Related]
5. Rapid regression of squamous cell hyperplasia and slow regression of basal cell hyperplasia in the forestomach of F344 rats treated with N-methyl-N'-nitro-N-nitrosoguanidine and/or butylated hydroxyanisole. Tatematsu M; Ogawa K; Mutai M; Aoki T; Hoshiya T; Ito N Cancer Res; 1991 Jan; 51(1):318-23. PubMed ID: 1703036 [TBL] [Abstract][Full Text] [Related]
6. Effects of butylated hydroxyanisole, butylated hydroxytoluene, and NaCl on gastric carcinogenesis initiated with N-methyl-N'-nitro-N-nitrosoguanidine in F344 rats. Shirai T; Fukushima S; Ohshima M; Masuda A; Ito N J Natl Cancer Inst; 1984 May; 72(5):1189-98. PubMed ID: 6585594 [TBL] [Abstract][Full Text] [Related]
7. Regression of simple hyperplasia and papillomas and persistence of basal cell hyperplasia in the forestomach of F344 rats treated with butylated hydroxyanisole. Masui T; Asamoto M; Hirose M; Fukushima S; Ito N Cancer Res; 1987 Oct; 47(19):5171-4. PubMed ID: 3621202 [TBL] [Abstract][Full Text] [Related]
8. A carcinogenesis reversibility study of the effects of butylated hydroxyanisole on the forestomach and urinary bladder in male Fischer 344 rats. Nera EA; Iverson F; Lok E; Armstrong CL; Karpinski K; Clayson DB Toxicology; 1988 Dec; 53(2-3):251-68. PubMed ID: 3212786 [TBL] [Abstract][Full Text] [Related]
9. Modifying effects of concomitant treatment with butylated hydroxyanisole or butylated hydroxytoluene on N,N-dibutylnitrosamine-induced liver, forestomach and urinary bladder carcinogenesis in F344 male rats. Imaida K; Fukushima S; Inoue K; Masui T; Hirose M; Ito N Cancer Lett; 1988 Dec; 43(3):167-72. PubMed ID: 3203335 [TBL] [Abstract][Full Text] [Related]
10. Dose response in butylated hydroxyanisole induction of forestomach carcinogenesis in F344 rats. Ito N; Fukushima S; Tamano S; Hirose M; Hagiwara A J Natl Cancer Inst; 1986 Dec; 77(6):1261-5. PubMed ID: 3467116 [TBL] [Abstract][Full Text] [Related]
11. Carcinogenicity of antioxidants BHA, caffeic acid, sesamol, 4-methoxyphenol and catechol at low doses, either alone or in combination, and modulation of their effects in a rat medium-term multi-organ carcinogenesis model. Hirose M; Takesada Y; Tanaka H; Tamano S; Kato T; Shirai T Carcinogenesis; 1998 Jan; 19(1):207-12. PubMed ID: 9472713 [TBL] [Abstract][Full Text] [Related]
12. Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of gamma-glutamyl transpeptidase-positive foci development in the liver of rats. Imaida K; Fukushima S; Shirai T; Ohtani M; Nakanishi K; Ito N Carcinogenesis; 1983; 4(7):895-9. PubMed ID: 6135514 [TBL] [Abstract][Full Text] [Related]
13. Studies on antioxidants: their carcinogenic and modifying effects on chemical carcinogenesis. Ito N; Hirose M; Fukushima S; Tsuda H; Shirai T; Tatematsu M Food Chem Toxicol; 1986; 24(10-11):1071-82. PubMed ID: 3804112 [TBL] [Abstract][Full Text] [Related]
14. Inhibiting effects of diethylmaleate or NH4Cl on NaHCO3, but not butylated hydroxyanisole, promotion of urinary bladder carcinogenesis in male F344 rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Hagiwara A; Tanaka H; Tamano S; Imaida K; Takahashi S; Fukushima S J Toxicol Sci; 1994 Nov; 19(4):189-95. PubMed ID: 7884829 [TBL] [Abstract][Full Text] [Related]
15. Co-carcinogenic effect of retinyl acetate on forestomach carcinogenesis of male F344 rats induced with butylated hydroxyanisole. Hasegawa R; Takahashi M; Furukawa F; Toyoda K; Sato H; Hayashi Y Jpn J Cancer Res; 1988 Mar; 79(3):320-8. PubMed ID: 3131282 [TBL] [Abstract][Full Text] [Related]
16. Effects of butylated hydroxyanisole pretreatment on low dose N-methyl-N'-nitro-N-nitrosoguanidine- or N,N-dibutylnitrosamine-induced rat forestomach or esophageal carcinogenesis. Hirose M; Uwagawa S; Ozaki K; Takaba K; Ito N Carcinogenesis; 1991 Oct; 12(10):1773-6. PubMed ID: 1934256 [TBL] [Abstract][Full Text] [Related]
17. Dose-dependent effects of butylated hydroxyanisole, butylated hydroxytoluene and ethoxyquin for promotion of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats. Fukushima S; Ogiso T; Kurata Y; Hirose M; Ito N Cancer Lett; 1987 Jan; 34(1):83-90. PubMed ID: 3802071 [TBL] [Abstract][Full Text] [Related]
18. Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine. Masui T; Shirai T; Takahashi S; Mutai M; Fukushima S Carcinogenesis; 1988 Nov; 9(11):1981-5. PubMed ID: 3180336 [TBL] [Abstract][Full Text] [Related]
19. Enhancing effect of concomitant L-ascorbic acid administration on BHA-induced forestomach carcinogenesis in rats. Shibata MA; Hirose M; Kagawa M; Boonyaphiphat P; Ito N Carcinogenesis; 1993 Feb; 14(2):275-80. PubMed ID: 8435867 [TBL] [Abstract][Full Text] [Related]
20. Selective induction of rat urinary bladder tumors by simultaneous administration of 3,2'-dimethyl-4-aminobiphenyl (DMAB) and butylated hydroxyanisole or butylated hydroxytoluene is associated with increased DMAB-DNA adduct formation. Shirai T; Fukushima S; Kawabe M; Shibata M; Iwasaki S; Tada M; Ito N Carcinogenesis; 1991 Jul; 12(7):1335-9. PubMed ID: 1906380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]